NIVABUPA NSE filing

Niva Bupa Q2 FY26 Earnings Call Transcript

The RealCase readMedium impact Positive

Niva Bupa released Q2 FY26 earnings call transcript. H1 saw 23% growth, ₹132 crore PAT, and a combined ratio of 103.1%. GST reduction is expected to boost demand.

Why it matters

The earnings call transcript provides insights into the company's performance and strategy. The positive financial results and commentary on growth drivers suggest a moderate positive impact.

The market read

The announcement highlights positive financial performance, including growth in GWP, PAT, and improvement in the combined ratio. The CEO's commentary on GST reduction is also optimistic.

* Niva Bupa Health Insurance Company Limited released the transcript of its Q2 FY26 earnings conference call held on 3 November 2025. * The company achieved an overall growth rate of 23% and a retail growth rate of 28% for H1. * IFRS PAT for H1 improved to ₹132 crore from ₹60 crore in the same period last year. * The combined insurance service ratio for H1 improved by more than 100 basis points to 103.1%. * The settlement ratio for Q2 on claims was 95.2%. * The company launched ReAssure 3.0, a next-generation retail health insurance product. * GWP for H1 is ₹3,983 crore, registering a growth rate of 23%. * Annualized investment yield for H1 FY '26 is 7.3% with AUM of ₹8,482 crore. * Solvency ratio is at a healthy level of 2.85x as on 30th September 2025. * Krishnan Ramachandran, MD and CEO, stated that the reduction of GST from 18% to 0% on health insurance is a significant win for the industry and should boost demand. * The company has increased its headcount by more than 1,000 and set up an AI lab.

Filing to action

What to do with a filing like this

Niva Bupa Health Insurance Company Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Niva Bupa Health Insurance Company Limited. Read the original for the full detail.

View original filing